Does ATORVASTATIN Cause Forced expiratory volume decreased? 21 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Forced expiratory volume decreased have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.0% of all adverse event reports for ATORVASTATIN.
21
Reports of Forced expiratory volume decreased with ATORVASTATIN
0.0%
of all ATORVASTATIN reports
0
Deaths
21
Hospitalizations
How Dangerous Is Forced expiratory volume decreased From ATORVASTATIN?
Of the 21 reports, 21 (100.0%) required hospitalization.
Is Forced expiratory volume decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Forced expiratory volume decreased?
OMALIZUMAB (1,497)
ALBUTEROL (344)
PREDNISONE (335)
MONTELUKAST (274)
TIOTROPIUM (236)
MEPOLIZUMAB (209)
METFORMIN (183)
BUDESONIDE\FORMOTEROL (171)
BUDESONIDE (150)
LEVOFLOXACIN (138)
Which ATORVASTATIN Alternatives Have Lower Forced expiratory volume decreased Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM